18 January 2024
Top hires for VC & PE portfolio companies Q4-2023
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Reconstructive surgery | Italy |
| CEO | Medical devices | Israel |
| CEO | Immuno-oncology platform | US |
| Chief Scientific Officer | Gene therapies | UK |
| Chief Business Officer | Precision biotherapeutics | Singapore |
| Chief Product Officer | Medical information services | UK |
| SVP Global Strategic Business Development | Drug discovery services | Germany |
| VP Drug Discovery & Preclinical Development | CNS platform | UK |
| Head of Clinical Operations | Small molecule biopharma | Denmark |
| Country Director | Life sciences investor | US |
| Head of Alliance Management | Incubator | UK |
| Chair | Medical devices | Israel |
| Chair | Tech enabled care provider | US |
| US-based Board Director | T-cell therapies | France |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Small molecule biopharma | Australia |
| CEO | Synthetic biology technologies | US |
| CEO | Protein alternatives | US |
| Chief Financial Officer | Remote monitoring | France |
| Chief Operating Officer | Contract research services | Germany |
| Chief Scientific Officer | Gene therapies | US |
| Chief of Staff | Vaccines | Denmark |
| Chief Business Officer | Immuno-oncology platform | UK |
| Head of Tech Ops & Manufacturing, UK | Contract manufacturing services | US |
| VP BD Cell Therapy | Precision medicines | UK |
| VP Regulatory Affairs & Quality Assurance, Europe | Surgical devices | US |
| Director Market Access & Pricing Europe | Ophthalmology therapeutics | Italy |
| Marketing & Communications Director | AI for drug design | France |